Rice downgraded CVS Health's target price to $58.
Gelonghui, December 24|Mizuho: Downgraded CVS Health's target price from $66 to $58, maintaining an 'Outperform' rating. (Gelonghui)
Mizuho Securities Maintains CVS Health(CVS.US) With Buy Rating, Announces Target Price $58
Express News | Shares of CVS Health Corp Down 1.4% After Mizuho Cuts Target Price
Is the Stock Market Open on Christmas? Does the Post Office Deliver Mail?
Express News | RPT-Buzz-US Stocks Weekly: Snow Squall
Mizuho Adjusts Price Target on CVS Health to $58 From $66, Keeps Outperform Rating
S&P 500: 2024 Stars, Flops, and What's Hot for 2025
TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $80
Why CVS Health (CVS) Outpaced the Stock Market Today
Express News | Varo Bank Introduces Zero Fee Cash Deposits at Participating CVS Locations
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Prothena (PRTA) and CVS Health (CVS)
CVS Health: Strategic Buy Rating Amidst Industry Reforms and Valuation Opportunities
Why CVS Health (CVS) Is the Best Dividend Leader to Buy According to Wall Street Analysts?
This week's US stock market hot stocks | The US version of HAIDILAO exceeds expectations! Darden Restaurants' stock price skyrocketed nearly 15%; Boeing, a component of the Dow, rose 4.36% against the trend this week, receiving a large order for 737 MAX a
This week, the Dow Jones Industrial Average has fallen by 3.39%, closing at 42,342.24 points; during the same period, the S&P 500 Index has decreased by 3.04%, closing at 5,867.08 points; the Nasdaq has dropped by 2.78%, closing at 19,372.77 points.
CVS Health Options Spot-On: On December 19th, 133.75K Contracts Were Traded, With 900.53K Open Interest
On December 19th ET, $CVS Health(CVS.US)$ had active options trading, with a total trading volume of 133.75K options for the day, of which put options accounted for 64.36% of the total transactions,
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Baird Adjusts CVS Health Price Target to $51 From $61, Maintains Neutral Rating
Peering Into CVS Health's Recent Short Interest
Wells Fargo Trim Price Target on CVS Health to $65 From $66